NCT02431650View on ClinicalTrials.gov

Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Malaria
Interventions
DRUG

OZ439

DRUG

Primaquine

Trial Locations (1)

4006

Q-Pharm Clinics, Herston

Sponsors
All Listed Sponsors
collaborator

Q-Pharm Pty Limited

INDUSTRY

collaborator

Clinical Network Services (CNS) Pty Ltd

INDUSTRY

collaborator

Sullivan Nicolaides Pathology

INDUSTRY

collaborator

QIMR Berghofer Medical Research Institute

OTHER

collaborator

Army Malaria Institute, Australia

OTHER

lead

Medicines for Malaria Venture

OTHER

NCT02431650 - Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent | Biotech Hunter | Biotech Hunter